Foghorn Therapeutics Inc. Operating Lease, Liability, Noncurrent
Foghorn Therapeutics Inc. (FHTX) had Operating Lease, Liability, Noncurrent of $40.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $40.28M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $40.13M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $40.35M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $15.77M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $40.28M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $40.13M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $40.35M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $15.77M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $17.52M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $25.74M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $28.06M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $30.30M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $28.06M 10-Q · filed 2025-08-05 | $32.54M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $34.31M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $36.55M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $38.71M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $40.27M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $43.49M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $45.54M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $46.50M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $49.14M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $50.48M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $51.34M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $53.02M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $54.80M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $56.55M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $58.36M 10-K/A · filed 2022-08-09 | |
| 2020-09-30 | $56.01M 10-Q · filed 2020-12-04 | |
| 2019-12-31 | $157.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |